Delaware Court Nullifies Another Purdue Pharma OxyContin Patent Amid Bankruptcy Struggles

A Delaware federal court decided on Monday to invalidate another patent issued to bankrupt OxyContin maker Purdue Pharma. This ruling comes a year and a half after a similar judgment was made in a different case involving Purdue’s attempts to block the same prospective Indian manufacturer of generic painkillers. For more details, visit the original article.